A phase II clinical trial of frameless, fractionated stereotactic radiation therapy for brain metastases is a research paper published in JNCI Cancer Spectrum (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R50CA275822-01
A radiation oncology clinician scientist devoted to building an inclusive clinical research program in an integrated academic satellite network in service to the National Cancer Institute
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
FWCI
0.17
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords